~31 spots leftby Jan 2026

Healthy Lifestyle Program for Heart Disease Risk Reduction

(MBC2 Trial)

Recruiting in Palo Alto (17 mi)
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: Nancy Schoenberg
Must not be taking: Weight loss medication
Disqualifiers: Unstable medical conditions, Cognitive impairment, Psychiatric hospitalization, others
No Placebo Group

Trial Summary

What is the purpose of this trial?

This trial tests the MBC2 program, which uses an app, fitness tracker, health coaching, and rewards to improve diet and exercise habits. It targets adults in rural Appalachia, Kentucky who have poor health profiles. The program helps participants track their habits, get personalized advice, and earn rewards for meeting health goals.

Will I have to stop taking my current medications?

The trial does not specify whether you need to stop taking your current medications, but it does exclude those taking weight loss medication.

What data supports the effectiveness of the treatment Adapted MBC2 Program, Stress Management Control for heart disease risk reduction?

Research shows that lifestyle programs focusing on diet, exercise, stress management, and social support can significantly improve heart health. These programs have been effective in reducing risk factors like blood pressure and cholesterol, and improving quality of life in people with heart disease.12345

Is the Healthy Lifestyle Program for Heart Disease Risk Reduction safe for humans?

In a study involving a lifestyle modification program with dietary supplements, no adverse events related to the diet or supplements were reported, indicating it was generally safe for participants.678910

How is the Adapted MBC2 Program treatment different from other treatments for heart disease risk reduction?

The Adapted MBC2 Program is unique because it focuses on a comprehensive lifestyle modification approach, which includes multiple components like physical exercise, healthy eating habits, and psychological support to improve adherence and reduce heart disease risk factors, unlike standard treatments that may focus solely on medication or single lifestyle changes.411121314

Research Team

Eligibility Criteria

This trial is for adults living in Appalachian Kentucky who want to improve their health habits. Participants should be willing to use a smartphone app and wear an accelerometer, spend over 90 minutes daily on recreational screen time, eat less than 4.5 cups of fruits/vegetables daily, engage in less than 150 minutes of physical activity weekly, and consume more than 8% of their calories from saturated fat.

Inclusion Criteria

Willingness to use smart phone to record and modify diet and activity
Engages in less than 150 minutes of moderate-intensity physical activity weekly
I am willing to wear a movement tracking device.
See 4 more

Exclusion Criteria

I use devices to help me move around.
Unstable medical conditions
I have difficulty with memory or thinking clearly.
See 8 more

Trial Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive the adapted MBC2 or stress management program, utilizing a smartphone app, accelerometers, telephone coaching, and behavioral incentives to improve diet and physical activity or manage stress.

9 months
Monthly virtual check-ins

Follow-up

Participants are monitored for changes in diet, activity, and health-related outcomes after the intervention period.

3 months

Treatment Details

Interventions

  • Adapted MBC2 Program (Behavioural Intervention)
  • Stress Management Control (Behavioural Intervention)
Trial OverviewThe study tests the 'Adapted MBC2 Program' which includes an app, accelerometer tracking, health coaching sessions, and incentives aimed at increasing fruit/vegetable intake and physical activity while reducing saturated fat consumption and sedentary screen time among participants.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Adapted MBC2 GroupExperimental Treatment1 Intervention
The Adapted MBC2 Program will utilize a smart phone app, accelerometers, telephone coaching, and behavioral incentives to target fruit and vegetable intake, dietary fat intake, physical activity, and high sedentary leisure screen time. Participants will wear accelerometers, log hours slept, enter real-time information about their relaxation exercises and stress, and monitor goal thermometers to meet targets.
Group II: Stress Management GroupActive Control1 Intervention
The Stress Management Program will utilize a smart phone app, accelerometers, telephone coaching, and behavioral incentives to target stress, relaxation, and sleep. Participants will wear accelerometers, log hours slept, enter real-time information about their relaxation exercises and stress, and monitor 3 goal thermometers (sleep, relaxation, stress) to meet behavioral targets. The Stress Management Program, including the use of the app and assessments, is identical to the Adapted MBC2 program, with the exception of the content.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Nancy Schoenberg

Lead Sponsor

Trials
5
Recruited
3,900+

National Heart, Lung, and Blood Institute (NHLBI)

Collaborator

Trials
3,987
Recruited
47,860,000+
Dr. Gary H. Gibbons profile image

Dr. Gary H. Gibbons

National Heart, Lung, and Blood Institute (NHLBI)

Chief Executive Officer since 2012

MD from Harvard Medical School

Dr. James P. Kiley profile image

Dr. James P. Kiley

National Heart, Lung, and Blood Institute (NHLBI)

Chief Medical Officer since 2011

MD from University of California, San Francisco

Findings from Research

A systematic review of 40 trials involving 35,548 participants found that Mediterranean dietary programmes significantly reduce all-cause mortality, cardiovascular mortality, stroke, and non-fatal myocardial infarction compared to minimal interventions, indicating their efficacy in patients at increased cardiovascular risk.
Low fat dietary programmes also showed effectiveness in reducing all-cause mortality and non-fatal myocardial infarction, but there were no significant differences in outcomes between Mediterranean and low fat diets, suggesting both are beneficial for heart health.
Comparison of seven popular structured dietary programmes and risk of mortality and major cardiovascular events in patients at increased cardiovascular risk: systematic review and network meta-analysis.Karam, G., Agarwal, A., Sadeghirad, B., et al.[2023]
A study of 440 patients with coronary artery disease showed that a multi-component lifestyle change program significantly improved diet, exercise, stress management, and overall health outcomes over 12 months, benefiting both men and women equally.
The program is particularly advantageous for women, who typically face higher risks of mortality and morbidity from heart-related issues, suggesting it could help address gender disparities in heart disease outcomes.
Improvement in medical risk factors and quality of life in women and men with coronary artery disease in the Multicenter Lifestyle Demonstration Project.Koertge, J., Weidner, G., Elliott-Eller, M., et al.[2022]
A 6-month structured lifestyle intervention for patients with cardiovascular disease (CVD) significantly improved physical activity and reduced body mass index (BMI) and waist circumference, indicating its effectiveness in enhancing cardiovascular risk profiles.
Despite patients receiving optimal usual care and cardioprotective drug treatment, the lifestyle intervention provided additional benefits, highlighting the importance of lifestyle modifications alongside medication in managing cardiovascular risk factors.
The effect of a comprehensive lifestyle intervention on cardiovascular risk factors in pharmacologically treated patients with stable cardiovascular disease compared to usual care: a randomised controlled trial.Ijzelenberg, W., Hellemans, IM., van Tulder, MW., et al.[2021]

References

Comparison of seven popular structured dietary programmes and risk of mortality and major cardiovascular events in patients at increased cardiovascular risk: systematic review and network meta-analysis. [2023]
Improvement in medical risk factors and quality of life in women and men with coronary artery disease in the Multicenter Lifestyle Demonstration Project. [2022]
The effect of a comprehensive lifestyle intervention on cardiovascular risk factors in pharmacologically treated patients with stable cardiovascular disease compared to usual care: a randomised controlled trial. [2021]
Community programmes for coronary heart disease in Spanish primary care. [2017]
Intensive lifestyle modification: impact on cardiovascular disease risk factors in subjects with and without clinical cardiovascular disease. [2019]
Adherence to a Mediterranean diet and cardio-metabolic risk in postmenopausal women by body composition. [2022]
[Efficacy of an educational intervention group on changes in lifestyles in hypertensive patients in primary care: a randomized clinical trial]. [2019]
A 13-week low glycemic load diet and lifestyle modification program combining low glycemic load protein shakes and targeted nutraceuticals improved weight loss and cardio-metabolic risk factors. [2018]
Regression of coronary atherosclerosis through healthy lifestyle in coronary artery disease patients--Mount Abu Open Heart Trial. [2019]
10.United Statespubmed.ncbi.nlm.nih.gov
Sustained body weight reduction by an individual-based lifestyle intervention for workers in the construction industry at risk for cardiovascular disease: results of a randomized controlled trial. [2022]
Two-year results of a controlled study of residential rehabilitation for patients treated with percutaneous transluminal coronary angioplasty. A randomized study of a multifactorial programme. [2022]
Predictors of adherence in a prevention program for patients with metabolic syndrome. [2018]
Long-term effects of lifestyle on multiple risk factors in male workers. [2021]
Outcomes of a comprehensive healthy lifestyle program on cardiometabolic risk factors in a developing country: the Isfahan Healthy Heart Program. [2022]